Exploring Three German Growth Companies With High Insider Ownership On The Exchange

As inflation and policy adjustments stir the European markets, Germany's DAX index has recently faced a decline, reflecting broader uncertainties. In this context, exploring growth companies with high insider ownership in Germany offers an intriguing perspective on potential resilience and long-term value creation in turbulent times.

Top 10 Growth Companies With High Insider Ownership In Germany

Name	Insider Ownership	Earnings Growth
pferdewetten.de (XTRA:EMH)	26.8%	73.8%
Deutsche Beteiligungs (XTRA:DBAN)	35.3%	31.6%
YOC (XTRA:YOC)	24.8%	22.2%
NAGA Group (XTRA:N4G)	14.1%	58.1%
Exasol (XTRA:EXL)	25.3%	107.4%
Alelion Energy Systems (DB:2FZ)	37.4%	106.6%
Stratec (XTRA:SBS)	30.9%	22%
elumeo (XTRA:ELB)	25.8%	99.1%
Redcare Pharmacy (XTRA:RDC)	17.7%	46.9%
Friedrich Vorwerk Group (XTRA:VH2)	18%	29.9%

Click here to see the full list of 17 stocks from our Fast Growing German Companies With High Insider Ownership screener.

Let's review some notable picks from our screened stocks.

Redcare Pharmacy (XTRA:RDC)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Redcare Pharmacy NV is an online pharmacy operating across the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market capitalization of approximately €2.37 billion.

Operations: The company generates €1.62 billion from its DACH region operations and €0.37 billion internationally.

Insider Ownership: 17.7%

Redcare Pharmacy, a German growth company with high insider ownership, reported a notable increase in sales to €560.22 million from €372.05 million year-over-year in Q1 2024, alongside a reduced net loss of €7.81 million. Despite past shareholder dilution and highly volatile share prices recently, the company is poised for significant earnings growth at an annual rate of 46.92%. It trades at 41.1% below estimated fair value and is expected to become profitable within three years, outpacing average market growth predictions.

• Click here to discover the nuances of Redcare Pharmacy with our detailed analytical future growth report.
• According our valuation report, there's an indication that Redcare Pharmacy's share price might be on the expensive side.

Stratec (XTRA:SBS)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Stratec SE operates in Germany and internationally, designing and manufacturing automation and instrumentation solutions for in-vitro diagnostics and life sciences, with a market capitalization of approximately €580.45 million.

Operations: The company generates its revenue from designing and manufacturing automation and instrumentation solutions for in-vitro diagnostics and life sciences across Germany, the European Union, and other global markets.

Insider Ownership: 30.9%

Stratec SE, a German company with high insider ownership, has shown mixed financial performance recently. In Q1 2024, sales dropped to €50.87 million from €60.48 million year-over-year, and net income decreased to €0.447 million from €1.37 million. Despite this downturn, the company's earnings are expected to grow by 22% per year, outperforming the German market forecast of 18.8% growth in earnings per annum. Stratec trades at a significant discount of 41.4% below its estimated fair value.

• Take a closer look at Stratec's potential here in our earnings growth report.
• The analysis detailed in our Stratec valuation report hints at an inflated share price compared to its estimated value.

Friedrich Vorwerk Group (XTRA:VH2)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Friedrich Vorwerk Group SE specializes in offering solutions for the transformation and transportation of energy across Germany and Europe, with a market capitalization of approximately €0.36 billion.

Operations: The company generates revenue primarily through segments focused on electricity (€72.07 million), natural gas (€157.60 million), clean hydrogen (€28.59 million), and adjacent opportunities (€118.73 million).

Insider Ownership: 18%

Friedrich Vorwerk Group SE, recognized for high insider ownership, is trading at 4.1% below its estimated fair value and shows promising growth prospects in Germany. The company's revenue is expected to increase by 6.7% annually, outpacing the German market's 5% growth rate. Earnings are projected to surge by nearly 30% each year, significantly above the market forecast of 18.8%. Recent financial results reflect a robust uptrend with Q1 2024 net income more than doubling year-over-year to €1.56 million from €0.748 million.

• Get an in-depth perspective on Friedrich Vorwerk Group's performance by reading our analyst estimates report here.
• The valuation report we've compiled suggests that Friedrich Vorwerk Group's current price could be inflated.

Where To Now?

• Unlock more gems! Our Fast Growing German Companies With High Insider Ownership screener has unearthed 14 more companies for you to explore.Click here to unveil our expertly curated list of 17 Fast Growing German Companies With High Insider Ownership.
• Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.
• Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Seeking Other Investments?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com